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Background: Electronic health records are widely used in cardiovascular disease research. 
We appraised the validity of stroke, acute coronary syndrome and heart failure diagnoses in 
studies conducted using European electronic health records.
Methods: Using a prespecified strategy, we systematically searched seven databases from dates 
of inception to April 2019. Two reviewers independently completed study selection, followed by 
partial parallel data extraction and risk of bias assessment. Sensitivity, specificity, positive 
predictive value (PPV), and negative predictive value estimates were narratively synthesized 
and heterogeneity between sensitivity and PPV estimates were assessed using I2.
Results: We identified 81 studies, of which 20 validated heart failure diagnoses, 31 validated 
acute coronary syndrome diagnoses with 29 specifically recording estimates for myocardial 
infarction, and 41 validated stroke diagnoses. Few studies reported specificity or negative 
predictive value estimates. Sensitivity was ≤66% in all but one heart failure study, ≥80% for 
91% of myocardial infarction studies, and ≥70% for 73% of stroke studies. PPV was ≥80% 
in 74% of heart failure, 88% of myocardial infarction, and 70% of stroke studies. PPV by 
stroke subtype was variable, at ≥80% for 80% of ischaemic stroke but only 44% of 
haemorrhagic stroke. There was considerable heterogeneity (I2 >75%) between sensitivity 
and PPV estimates for all diagnoses.
Conclusion: Overall, European electronic health record stroke, acute coronary syndrome 
and heart failure diagnoses are accurate for use in research, although validity estimates for 
heart failure and individual stroke subtypes were lower. Where possible, researchers should 
validate data before use or carefully interpret the results of previous validation studies for 
their own study purposes.
Keywords: validation, myocardial infarction, heart failure, stroke; routinely collected health 
data
Introduction
Ischaemic heart disease and cerebrovascular disease have been the leading causes 
of death globally for more than 15 years.1 In Europe, cardiovascular disease (CVD) 
deaths and prevalence have decreased but remain substantial; in 2015 an estimated 
85 million people had CVD including 11.3 million with new diagnoses.2
CVD determinants and outcomes research increasingly utilize electronic health 
records (EHRs). EHRs contain comprehensive longitudinal health data, extracted 
from primary and secondary care clinical systems, for large patient populations 
which provide cost-effective data for research. EHR data is mostly “structured” 
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with diagnoses coded using, for example, the International 
Classification of Diseases (ICD) but can also be “unstruc-
tured” with anonymized free-text notes.3 EHR-based 
research predominantly uses structured data. As the pri-
mary purpose of EHR data collection is clinical, it is 
essential to consider the validity of the data’s use in 
research.
EHR use is widespread in Europe, where many coun-
tries have national healthcare systems, and several sys-
tematic reviews have previously explored the quality of 
specific European EHRs.4–7 Other systematic reviews8–12 
have investigated the validity of CVD diagnoses in com-
puterized health-related records, which included EHRs but 
mainly drew results from disparate claims-based systems. 
The previous reviews did not separate results for EHR and 
claims data, the quality of which may differ due to the 
differences in setup and collection rationale.
In our systematic review, we provide an up-to-date 
assessment of the validity of acute CVD diagnoses 
recorded in European EHRs. We defined acute CVD as 
heart failure (HF), acute coronary syndrome (ACS), and 
stroke. These high-burden conditions are key diagnoses 
commonly included in the composite endpoint of major 
adverse cardiovascular events (MACE) which is increas-
ingly employed in both clinical trials and observational 
research studies.13 We investigated whether the validity of 
these diagnoses differed by subtype, definition, data 
source, reference standard, and study population.
Methods
Protocol and Registration
Our protocol was published in October 201914 following 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Protocol guidelines (PROSPERO registra-
tion number CRD42019123898).
Eligibility Criteria
We included articles that validated diagnoses in patients 
aged ≥16 years captured in any European primary or 
secondary care EHR. We excluded claims-based data-
bases, disease registries, vital registration systems, or 
locally held databases. Articles needed to validate clinical 
codes for the diagnoses of HF, ACS, or stroke (Table 1) 
against a suitable internal or external reference standard. 
HF is most frequently a chronic condition which can 
deteriorate with acute exacerbations. HF may also have 
an acute onset, for example after an MI. The European 
Society of Cardiology (ESC) defines acute HF as rapid 
onset or worsening of symptoms and/or signs of existing 
HF.15 ACS encompasses different clinical forms of myo-
cardial ischaemia which includes myocardial infarction 
(MI) and unstable angina. The specific diagnosis of MI 
or unstable angina depends on symptoms, signs, biomar-
kers, and ECG and/or autopsy findings, with the defini-
tions refined over time.16 The diagnosis of stroke includes 
subtypes ischaemic stroke, intracerebral haemorrhage 
(ICH), and subarachnoid haemorrhage (SAH).17 At least 
one validation estimate (Figure 1) or the raw data to 
calculate it was required.
Information Sources
We searched for eligible articles in five databases 
(Medline, Embase, Scopus, Web of Science, and 
Cochrane Library), two grey literature sources 
(OpenGrey and Ethos), and, where available, the biblio-
graphies of EHR databases from the date of inception to 
April 2019 in any language.
Search Strategy
We searched medical subject heading terms and free-text 
(in the title and abstract) for the concepts of (1) CVD 
Table 1 Example Clinical Codes Included for Stroke, Acute Coronary Syndrome and Heart Failure Diagnosis Definitions
Diagnosis Subtype ICD-10 ICD-9 ICPC
Acute coronary syndrome Myocardial infarction I21 410 K75
Unstable angina I20.0
Cardiac arrest I46
Other acute heart disease I24 411
Heart failure I50 428 K77
Stroke Subarachnoid haemorrhage I60 430 K90
Intracerebral haemorrhage I61 431, 432
Cerebral infarction I63 433, 434
Non-specific stroke I64 436
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diagnoses, (2) EHRs, (3) Europe, and (4) validation. 
Search terms were developed for Medline and transcribed 
for the remaining databases (S1 Appendix). To identify 
any additional articles, we checked reference lists of eli-
gible articles and relevant systematic reviews.
Study Selection and Data Collection
Two reviewers (J.A.D. and R.M.) independently screened 
the titles and abstracts of all retrieved articles, followed by 
the full-text of articles deemed eligible in the first stage. 
Our published protocol details the full data collection 
process.14 Briefly, we extracted data using a pre-defined 
template (S2 Appendix) which we piloted using dual 
extraction for three studies, followed by further parallel 
extraction for 20% of studies, and completed by a single 
reviewer (J.A.D.) for the remaining studies.
Risk of Bias in Individual Studies
We used a modified version of the Quality Assessment of 
Diagnostic Accuracy Studies 2 (QUADAS-2)18 tool to 
assess bias (S3 Appendix). As with our data extraction, 
two authors (J.A.D. and R.M.) piloted the tool for three 
studies, then independently assessed risk in a further 10% 
of studies, with the process completed by a single reviewer 
(J.A.D.).
Synthesis of Results
We synthesized results with a narrative approach, grouping 
studies by acute CVD diagnosis (HF, ACS or stroke) and, 
where possible, subgroups of interest. Subgroups were; 
diagnosis type, definition, data source including diagnostic 
position and coding system, reference standard, and study 
population including time period, age and sex. For studies 
that reported validation estimates without confidence inter-
vals (CIs), but included raw data, we calculated 95% CIs 
using the Wilson method for binomial proportions. We 
used the I2 statistic to assess heterogeneity between the 
sensitivity and positive predictive value (PPV) estimates, 
following the Cochrane thresholds.19 Heterogeneity 
assessment did not include specificity or negative predic-
tive value (NPV), as few studies reported these measures. 
To investigate sources of heterogeneity, we compared I2 
before and after removing studies at a high risk of bias and 
by the previously mentioned subgroups. We used the Stata 
metaprop command20 to calculate I2. Metaprop uses raw 
data rather than precalculated estimates; studies that 
reported sensitivity or PPV but not the data used to calcu-
late were excluded from heterogeneity assessment.
Risk of Bias Across Studies
We used the Grading of Recommendations, Assessment, 
Development, and Evaluation (GRADE) tool for diagnos-
tic accuracy systematic reviews21 to summarise cross- 
study quality. Evidence was categorised as “high”, “mod-
erate”, “low” or “very low” quality. See S4 Appendix for 
the reasons we rated quality down or up.
Results
Studies Included
We identified 4595 studies, of which 218 were included in 
full-text review and 81 met eligibility criteria (Figure 2).
Study characteristics are summarized in S1 Table, 
results are displayed in S2 Table, Figures 3–8 and S1–6 
Figs, additional subgroup results are described in S5 
Appendix, QUADAS-2 results are in S3 Table, and our 
GRADE assessment is detailed in S4 Table.
Study Characteristics
The 81 included studies validated EHRs from 11 different 
countries, most frequently Denmark (18 studies)22–39 and the 
UK (17 studies).40–56 Validation was the primary aim of all 
but 10 studies.35,36,41,48,57–62 Fourteen studies26,27,31,63–73 
validated a vital registration system or disease registry in 
Figure 1 Illustration of validity estimates calculations.
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Figure 2 Flow diagram of study selection.
Figure 3 Positive predictive value for heart failure diagnoses from studies which reported the number of records confirmed positive and the total number of records. 
Abbreviations: D, definite; D & Pr, definite and probable; D, Pr & P, definite, probable and possible; P, primary; P/S, primary or secondary.
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addition to the EHR. The records validated included data 
from 1969–2015. Where ICD coding was validated this 
covered versions 8–10. Sixty studies used medical record 
review as a reference standard.22,23,25–39,42,43,45,46,49, 
50,54,55,57–63,69,72,74–96 Twenty studies validated HF,24,28– 
30,33,43,46,54,59,65,67,77,82,83,85,88,94–97 31 ACS22,23,26,27,29,30, 
32,34,37,42,46,47,50,52,53,58,65,68–70,75,76,80,81,84,87,88,91,98–100 and 
41 stroke diagnoses.25,31,32,35,36,38–41,44,45,47–49,51,55–57,60–64, 
66,71–74,78,79,81,86,87,89–93,98,101,102
Study Quality
Study quality was high for 54 (67%) of studies,22– 
26,28,29,31–34,38,39,42–44,47,50,51,53,54,56,59,60,62–65,67–70,72, 
73,75–79,85–90,92–94,96,98–102 medium for 19 (24%) 
studies27,30,35–37,46,49,52,55,57,58,61,66,74,81–84,95 and low 
for eight (10%) of studies.40,41,45,48,71,80,91,97 Studies 
were overall at low risk of bias in patient selection 
(76 low, 3 unclear, 2 high), index test (71 low, 10 
high), and flow and timing (78 low, 3 unclear) domains 
and higher risk in the reference standard domain (36 
low, 28 unclear, 17 high). Generally, reference standard 
methods and definitions were poorly described, and on 
occasion the reference standard was not independent of 
the EHR. Risk of bias was also higher in studies which 
validated primary care EHRs. HF validation studies 
had high quality in 14 (70%) studies, medium in five 
(25%) and low in one (5%). For ACS validation, qual-
ity was high for 21 (68%), medium for eight (26%) and 
low for two (6%) studies. In stroke validation studies, 
quality was high for 26 (63%), medium for nine (22%) 
and low for six (15%) studies.
Heart Failure Study Characteristics
HF diagnoses were most extensively validated using EHR 
data from Denmark (five studies),24,28–30,33 the Netherlands 
(four studies),59,65,94,95 Sweden (three studies)82,83,88 and 
the UK (three studies).43,46,54 In addition, EHR data from 
Finland,67 France,77 Germany,85 Italy97 and Spain96 were 
validated in one study each. Fourteen studies validated 
secondary care EHRs24,28–30,33,43,54,59,65,67,77,83,85,88 and 
six studies validated primary care EHRs.46,82,94–97 
Medical record review was used as the reference standard 
in all but three studies.24,65,97
Heart Failure Validation Results
Overall
From the main validation result reported by each of the 
studies; sensitivity (available from nine studies)-
24,46,65,67,77,82,85,88,95 was ≥50% in six studies46,77,82,85,88,95 
but >66% (range 11–100%) in only one study,46 PPV (19 
Figure 4 Sensitivity for heart failure diagnoses from studies which reported the number of records confirmed positive and the total number of records. 
Abbreviations: D & Pr, definite and probable; Pr & P, probable and possible; P, primary; P/S, primary or secondary.
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studies)24,28–30,33,43,46,54,59,65,67,77,83,85,88,94–97 was ≥80% 
(range 54–100%) in all but five studies,29,67,94,96,97 speci-
ficity (three studies)24,67,95 was ≥95% in all studies, and 
NPV (three studies)24,67,95 was ≥84% (range 84–96%) in 
all studies.
Diagnosis Type
In the three studies that reported results for first diagnosis, 
the PPV range was 76–88%.28,29,77 One study compared 
the PPV for all diagnoses (84%) to first diagnosis (80%),28 
and another study found the same PPV for first diagnosis 
and recurrent diagnosis (both 76%).29
Definition
In seven of the eight studies24,28,33,43,54,77,83,94 which used 
the ESC definition,15 the PPV was ≥80%. The study94 with 
the lower PPV of 64% was the only one to validate a 
primary care EHR. Other studies used; both 
Framingham103 and Boston104 criteria (one study,59 PPV 
80–81%), the American College of Cardiology (ACC)/ 
American Heart Association (AHA) definition105 (one 
study,97 PPV 55%), or study-specific definitions (three 
studies,67,95,96 PPV 54–83%). An overview of the defini-
tions used by the studies is presented in S6 Appendix.
Seven studies reported classification criteria; the PPV for 
definite HF ranged between 61–82%,33,43,54,77,83 including 
both definite and probable HF increased the PPV to 
73–88%33,43,54,77,83,94 and the two studies which additionally 
included possible HF reported high PPV as 87%54 and 96%.43
Diagnostic Position
Six studies29,33,43,54,77,83 reported HF recorded in any 
diagnostic position (PPV 76–96%) and two studies30,88 
only included primary position (PPV 87% and 100%). 
Three studies,33,77,83 which validated any position, also 
included breakdowns by primary (PPV 88–96%) and sec-
ondary (PPV 66–84%) positions.
Figure 5 Positive predictive value for myocardial infarction diagnoses from studies which reported the number of records confirmed positive and the total number of 
records. 
Abbreviations: D, definite; D & P, definite and possible; P, primary; P/S, primary or secondary; RS, reference standard.
Davidson et al                                                                                                                                                        Dovepress
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Coding System
Twelve studies validated ICD-10,24,28–30,33,43,54,67,77,82,83,96 
with all but one83 reporting results specifically for this ver-
sion of ICD (PPV 78–99%). Six studies24,33,43,77,82,96 vali-
dated I50; two studies of primary care EHRs reported lower 
validity estimates (PPV 54%96 and sensitivity 66%)82 com-
pared to four studies of secondary care EHRs (PPV 
81–96%,24,33,43,77 and sensitivity 29%24 and 64%).77 Five 
studies included a broader range of ICD-10 codes, all of 
which differed. The estimates for ICD-10 codes were no 
higher than those for ICD-8 (PPV 87%),67,83,88 ICD-9 
(PPV 79–97%),59,65,67,83 or combinations of the three ICD 
systems (PPV 73–82%).67,83 Two studies validated ICPC 
K77 in primary care EHRs (PPV 64%94 and 83%95).
Acute Coronary Syndrome Study 
Characteristics
Similar to HF, ACS diagnoses were most frequently vali-
dated using EHR data from Denmark (nine studies),-
22,23,26,27,29,30,32,34,37 followed by Finland (seven 
studies),68–70,81,84,99,100 the UK (six studies)42,46,47,50,52,53 
and Sweden (4 studies).58,80,87,88 Two studies validated 
data in each of Italy,23,75 the Netherlands,23,65 and 
Spain,91,98 and a final study used data from France.76 
Twenty-six of the studies validated a secondary care 
EHR,22,26,27,29,30,32,34,37,42,47,58,65,68–70,75,76,80,81,84,87,88,91, 
98–100 three studies validated both a primary and secondary 
care EHR23,50,53 and two studies validated a primary care 
EHR.46,52
Four studies22,37,68,76 presented overall ACS results, of 
which one study68 included an additional breakdown for 
MI and two studies37,76 included unstable angina and MI, 
one of which also included cardiac arrest.37 A further two 
studies29,65 did not report results for ACS overall but did 
include both unstable angina and MI. The remaining 25 
studies solely validated MI diagnoses.23,26,27,30,32, 
34,42,46,47,50,52,53,58,69,70,75,80,81,84,87,88,91,98–100
Acute Coronary Syndrome Validation 
Results
Overall
For ACS, three studies33,37,76 reported one main PPV 
(range 66–87%), while results presented by Pajunen et al68 
were broken down by age, sex and time period, with 
sensitivity of 66–87% and PPV of 63–86%.
Diagnosis Type
The PPV for unstable angina varied; with low values of 20%76 
and 27.5%37 in two studies and higher values of 78%65 and 
88%29 in the other two studies. Sensitivity was only reported 
by one study,65 at 53%. For MI, the main validation result for 
sensitivity (11 studies)26,27,34,42,46,50,58,65,81,88,98 was ≥80% in 
Figure 6 Sensitivity for myocardial infarction diagnoses from studies which reported the number of records confirmed positive and the total number of records. 
Abbreviations: D, definite; D & P, definite and possible; P, primary; P/S, primary or secondary; RS, reference standard.
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all but one study42 (range 56–97%), and six26,27,34,58,88,98 
>90%. PPV (24 studies)23,26,27,29,30,32,34,37,42,46,47,50,52,53,58,65, 
70,75,76,80,84,87,88,98 was ≥80% (range 42–100%) in all but three 
studies27,32,34 with 1223,29,30,42,50,52,53,65,87,88,98 ≥90%. Three 
studies34,42,98 reported specificity (range 93–100%) and two-
34,98 included NPV (range 82–100%).
Four studies29,32,37,84 reported the PPV for first MI, with 
estimates of 75–97%, and one study29 also included recurrent 
MI with a PPV of 88% compared to 97% for first MI.
Definition
Varying MI definitions were used (S6 Appendix). Most fre-
quently (nine studies)26,27,50,70,75,81,84,99,100 the World Health 
Organization (WHO) Monitoring trends and determinants in 
cardiovascular disease (MONICA) definition106 was used, 
with variable PPV estimates of 53–96% obtained. Two stu-
dies compared MONICA to another MI definition; one75 
showed MONICA-defined definite MI had a substantially 
lower PPV than AHA/ESC-defined16 definite MI (53% vs 
86%), while the other84 also showed a lower PPV for 
MONICA compared to “normal clinically defined MI” but 
with a smaller difference (81% vs 89%). One further study 
used the AHA/ESC definition37 (PPV 82%). The universal 
definition107 was used in a study23 which included EHR data 
from three countries, with PPVs of 75–100%. Three studies 
used the third universal definition,108 one76 of which com-
bined it with the earlier universal definition (PPV 85%). In 
another53 PPVs of 92% with obtained for the primary and 
secondary care EHRs validated. The third34 validated MI 
diagnoses recorded for patients with drug-eluting coronary 
stents, the PPV was 42% for all admission and 73% for acute 
admissions.
Diagnostic Position
Of the 10 studies which reported the diagnostic position 
used to validate MI diagnoses, five26,27,29,34,68 used any 
diagnostic position (PPV 42–97%) and five30,75,76,88,98 
primary position (PPV 53–100%). One study27 which 
Figure 7 Positive predictive value for stroke diagnoses recorded in secondary care EHRs from studies which reported the number of records confirmed positive and the 
total number of records. 
Abbreviations: ES, effect size; P, primary; P/S, primary or secondary.
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validated any position (PPV 79%) also included a break-
down by primary position (PPV 80%) and another study29 
included breakdowns by primary (PPV 99%) and second-
ary positions (PPV 80%).
Coding System
Ten studies validated ICD-10 coded MI, eight reported 
results specifically for ICD-10.23,29,30,32,34,47,53,76 Four stu-
dies validated ICD-10 I21 with PPV ≥85% (range 
42–100%)23,29,34,76 in all but one.34 Two studies included 
I21-I23 and reported high PPVs of 92%53 and 98%;30 
however, the latter study was small in size (50 patients). 
One study validated I21-I22 (PPV 89%)47 and another 
I21-I24 (PPV 75%).32 The estimates for ICD-10 codes 
were no higher than those for ICD-8 (PPV 
79–100%),26,27,80,84,88 ICD-9 (86–100%),42,50,58,65,75,98 or 
combinations of three ICD systems (PPV 82–96%).37,87 
Of the studies to validate data in primary care, one23 
included IPCI K75 code (PPV 75%) and three50,52,53 vali-
dated Read coding in the UK (PPV 91–93%).
Reference Standard
The PPV for MI diagnoses varied between 53–100% when 
medical record review was the reference standard (20 
studies)22,23,26,29,30,32,37,42,46,50,58,69,70,75,76,80,84,87,88,91 and 
89–93% when a registry was used.26,27,53,68,98–100 One 
study34 used medical record review after comparing EHR 
and registry results (PPV 42%). Two studies used a GP 
questionnaire (PPV 89% and 93%),47,52 and one study 
used a local cardiology database (PPV 97%).65
Stroke Study Characteristics
Stroke diagnoses were most frequently validated in UK EHRs, 
with 10 studies conducted,40,41,44,45,47–49,51,55,56 followed by 
Denmark (seven studies),25,31,32,35,36,38,39 Sweden (5 studies)-
60,64,66,71,87 and Italy (4 studies).74,86,90,93 Data from 
Finland,72,73,81 France,78,79,101 Norway,63,89,102 and 
Spain62,91,98 were validated in three studies each. A further 
two studies validated EHR data from the Netherlands57,61 and 
one from the Czech Republic.92 All but three studies41,44,48 
validated secondary care EHRs.
Figure 8 Sensitivity for stroke diagnoses recorded in secondary care EHRs from studies which reported the number of records confirmed positive and the total number of 
records. 
Abbreviations: ES, effect size; P, primary; P/S, primary or secondary.
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Twenty-eight studies presented validation estimates for 
overall stroke (including both ischaemic and haemorrhagic).-
25,31,32,35,38–41,44,45,48,49,56,60,63,64,66,71–73,81,86,87,91,92,98,101,102 
Ischaemic stroke was assessed in 18 studies,-
25,32,38,39,47,57,62,72–74,78,79,86,90,92,93,101,102 in all but four 
studies62,74,79,90 this was done as a subgroup analysis after 
validating overall stroke. Similarly, haemorrhagic stroke was 
assessed by 21 studies; two reported results for overall hae-
morrhagic stroke32,51 with this the main focus of one study,51 
17 studies reported results for ICH as a subgroup analysis-
25,38,39,47,51,55,57,72,73,78,86,87,89,92,93,101,102 and 18 studies 
reported results for SAH25,36,38,39,47,51,55,61,72,73,78, 
81,86,87,89,92,93,102 with this being the main result in two 
studies.36,61
Stroke Validation Results
Overall
For overall stroke, sensitivity (15 studies)-
31,40,45,49,56,63,64,71,73,81,86,91,98,101,102 was ≥80% (range 
33–97%) in seven studies49,63,64,71,73,81,102 and ≥70% in 11 
studies. PPV (27 studies)25,31,32,35,38–41,45,48,49,56,60,63,64,66,71– 
73,81,86,87,91,92,98,101,102 was ≥80% (range 20–97%) in 19 
studies.31,35,39–41,45,48,49,60,63,64,71,72,81,86,87,92,98 Nine of the 
studies31,32,40,49,60,63,64,71,101 did not include codes to validate 
SAH, three of which had stated this in their inclusion 
criteria.40,71,101 Excluding these studies did not affect the 
sensitivity (53–89%) or PPV (68–97%). Specificity and 
NPV, reported by five studies, were 99–100%49,56,63,98 
other than one study31 which obtained a specificity of 96% 
and NPV of 72%.
Diagnosis Type
Three studies56,64,101 included first and recurrent overall 
stroke with sensitivity from 71–89% and PPV 69–81%, 
while three studies32,71,73 also included only first stroke for 
which sensitivity was 85–89% and PPV 70–97%.
For ischaemic stroke, the main sensitivity reported (6 
studies)74,79,81,86,90,102 was ≥66% in all but one86 study 
(range 37–82%). Fourteen studies25,32,38,47,57,62,72,74, 
78,79,86,90,92,102 included one main PPV of 66–96%. One 
study101 classified results separately for cardiac embolism, 
large artery atherosclerosis, lacunar infarct and ischaemic 
stroke of other aetiology. Sensitivity and PPV were highest 
in the cardiac embolism classification (83% and 87%, 
respectively) and lowest for other aetiology (67% and 
35%, respectively). For ICH, the main sensitivity reported 
was 59–98% (4 studies)73,86,101,102 and main PPV 55–96% 
(15 studies).25,38,39,47,51,55,57,72,73,78,86,87,92,101,102 The 
sensitivity of SAH diagnoses was 35–92% (4 studies)-
73,81,86,102 and PPV was 42–96% (18 
studies).25,36,38,39,47,51,55,61,72,73,78,81,86,87,89,92,93,102
Definition
Stroke was defined in 22 of the 41 studies, 13-
25,31,35,38,39,63,66,71,81,86,90,92,101,102 used the WHO definition109 
(sensitivity 53–97%63,71,86,101,102 and PPV 68–97%),25,35,38,39, 
63,66,71,81,86,92,101,102 seven56,60,62,64,72,74,93 used MONICA110 
(sensitivity 71–89%56,64 and PPV 79–92%),56,60,64,72 and two-
32,87 defined stroke specifically for their study (PPV 70% and 
91%). The stroke definitions used are summarized in S6 
Appendix.
Diagnostic Position
For overall stroke diagnoses recorded in any diagnostic 
positions, sensitivity ranged from 53–97%56,63,86 and PPV 
from 69–90%.25,56,63,86 In comparison, results only for 
primary position were 67–86% for sensitivity and 
69–95% for PPV.49,63,73,98,101
Coding System
Thirteen studies validated ICD-10 (PPV 
20–97%,31,32,38,39,45,47,55,60,63,64,71,78,92 sensitivity 76–97%).45, 
63,64,71,101 Four studies31,63,64,71 which excluded SAH from the 
stroke definition validated ICD-10 I61, I63 and I64 (sensitivity 
89–97% and PPV 79–97%). Aboa-Eboule et al101 additionally 
included G46 in their definition (sensitivity 77% and PPV 
69%) while Dalsgaard et al32 validated I61-I65 (PPV 70%). 
In comparison, Holmqvist et al60 only included I61 and I63, 
and obtained PPV estimates of 92% and 89% in people with 
and without rheumatoid arthritis, respectively. Three studies-
38,39,92 which included SAH in the stroke definition validated 
I60, I61, I63 and I64 (PPV 79–86%) and one45 additionally 
included I62 (PPV 96%). The estimates for ICD-10 codes 
were no higher than those for ICD-8 codes (sensitivity 
82%),81 ICD-9 (PPV 20–95%,40,49,66,86,91,93,98,102 sensitivity 
33–89%),40,49,86,91,98,102 or combinations of three ICD systems 
(PPV 79–97%,35,72,73,87 sensitivity 71–85%).73
Seven studies validated ICD-10 I63 for ischaemic stroke 
diagnosis (PPV 78–96%).25,32,38,47,78,79,92 One study73 used 
a broad (ICD-9433, 434, 436 and ICD-10 I63, I64) and 
narrow range of codes (ICD-9433, 434 and ICD-10 I63) to 
define ischaemic stroke, with similar sensitivity (82% vs 
81%) and PPV (84% vs 83%). One other study74 reported 
results by ICD-9 codes 443*1 and 434*1 (PPV 86% and 
90%, respectively). Six studies25,38,55,78,89,92 validated ICD- 
10 I61, with another two39,101 presumed to have also vali-
dated this code, for ICH (PPV 66–96%) and a further three 
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studies86,93,102 validated ICD-9431 (PPV 71–78%). For 
SAH, eight studies25,38,39,47,55,78,89,92 validated ICD-10 I60 
with PPV >90% in half of the studies (range 46–96%), four 
studies61,86,93,102 validated ICD-9430 (PPV 42–95%), one 
study81 validated ICD-8430 (PPV 85%) and two studies72,87 
validated both versions for 430 (PPV 78–79%).
Reference Standard
In the 17 studies25,31,32,35,38,39,45,55,56,60,63,72,79,86,87,91,92 
which used medical record review as the reference stan-
dard to validate overall stroke diagnoses, the PPV was 
≥79% (range 20–97%) in all but four studies.25,31,32,91 A 
further eight studies used a registry reference standard 
(PPV 88–97%).40,64,66,71,73,98,101,102
Heterogeneity
We were able to assess the heterogeneity between the main 
PPV reported in; 14 studies with 16 estimates of HF 
(I2=97.0%), 18 studies with 26 estimates of MI 
(I2=98.5%), and 19 studies with 20 estimates of stroke 
(I2=97.9%) diagnoses. Additionally, we assessed heteroge-
neity between the main sensitivity for; six studies of HF 
(I2=98.6%), four of MI (I2=74.3%), and 11 of stroke 
(I2=98.8%) diagnoses. Heterogeneity between the esti-
mates was considerable, at more than >95% in all cases 
other than sensitivity estimates for MI. Furthermore, het-
erogeneity remained considerable after removal of studies 
at a high risk of bias.
Overall Strength of Evidence
GRADE showed that cross-study quality was very low for 
all HF outcomes (sensitivity and PPV in secondary care 
EHRs and PPV in primary care EHRs), low for MI sensi-
tivity and PPV in secondary care EHRs and moderate for 
PPV in primary care EHRs, and very low for stroke 
sensitivity in secondary care EHRs and PPV in primary 
care EHRs and moderate for PPV in secondary care EHRs.
Discussion
Summary of Findings
Our systematic review suggests that the sensitivity of 
coded data in European EHRs for HF diagnoses is low at 
≤66% in all but one study. There was also wide variation 
in stroke sensitivity estimates, with only half of studies 
≥80%, although three-quarters were ≥70%. The sensitivity 
of ACS was higher at ≥80% in the vast majority of studies. 
The majority of studies which validated ACS diagnosis did 
so specifically for MI.
The PPV of all diagnoses was ≥80% in the majority of 
studies; two-thirds for HF (nearly three-quarters for sec-
ondary care EHRs), nearly three-quarters for MI, and 70% 
of stroke validation studies. Where subtypes were vali-
dated, PPV was ≥80% for four-fifths of ischaemic stroke 
diagnoses but only 44% of ICH and SAH diagnoses.
The specificity and NPV were also high where avail-
able (three HF studies, three MI studies and five stroke 
studies). However, as most studies only included patients 
with the diagnosis of interest recorded in the EHR and 
reference standard, the results presented were mostly lim-
ited to sensitivity and PPV.
Both PPV and NPV are impacted by disease preva-
lence, with lower estimates for rare conditions.111 Our 
systematic review focused on Europe, drawing studies 
from 11 countries. Age-standardized prevalence of CVD 
in these countries is between 5000–6500 per 100,000, 
other than the Czech Republic (~8700 per 100,000) 
which only contributed one study.2 Therefore, prevalence 
differences should have limited impact on our comparison 
of validity estimates between geographies. The prevalence 
of CVD increases with age, but we did not find any 
systematic difference in results between studies with 
younger or older populations.
The low sensitivity of HF diagnoses we identified is 
consistent with a previous systematic review validating HF 
diagnoses in administrative data, which identified three 
European studies.11 Twelve more studies have since been 
published and included in our review. These more recent 
findings, however, do not suggest any improvement in the 
quality of data over time. This is perhaps unsurprising 
given the range of clinical aetiology and presentation. 
The high proportion of studies we found to have a PPV 
of <80% for stroke diagnoses appeared more substantial 
than in previous systematic reviews.9,12 We identified 15 
new studies which were not included in these previous 
reviews.25,32,45,51,56,57,61–63,74,78,89,91,92,98 Our results for 
sensitivity and PPV of MI diagnoses are consistent with 
previous reviews,8,10 and identified five29,32,34,76,98 new 
MI validation studies with variable results.
There was substantial heterogeneity between the sensi-
tivity and PPV estimates for all three acute CVD diag-
noses. Heterogeneity was likely because studies differed in 
multiple ways; for example, even among studies which 
used medical record review as the reference standard, 
differences in study time period impacted upon the ICD 
version used. The heterogeneity caused by variable meth-
ods was highlighted in previous systematic reviews of 
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atrial fibrillation and dementia diagnoses recorded in rou-
tine health data.112,113
Defining Diagnosis in the EHR
We were most interested in the results of ICD-10 valida-
tion, as this is the latest ICD coding system which is 
widely used in Europe and elsewhere. In McCormick 
et al’s10 review of MI diagnoses in administrative data, 
the authors noted a lack of ICD-10 validation with only 
three studies identified, whereas our review identified 10. 
Nevertheless, even within ICD-10, combinations of codes 
used, and therefore their validity, differed, which high-
lights the importance of tailoring codes to each research 
question. Codes are arguably even more important when 
using other, more complex coding systems such as Read 
codes, which are used in UK primary care data and can 
generate vast numbers of codes for every clinical 
condition.
Defining Diagnosis in the Reference 
Standard
There is no single recommended gold standard to determine 
the validity of EHR data.114 Nearly three-quarters (74%) of 
studies used medical records; more frequently for HF diag-
noses (85%) than ACS (71%) or stroke (68%). This differ-
ence may be due to availability of MI and stroke registries, 
used in 26% and 22% of studies, respectively. No differences 
in the performance of the reference standard methods were 
discernable, probably due to heterogeneity.
Criteria to define CVD, especially MI, have been 
refined over time, driven by the development of more 
sensitive and specific biomarkers, and more precise ima-
ging techniques.100 However, we did not identify any 
temporal trends in the accuracy of MI recording, again 
likely due to overall study heterogeneity.
When validating HF, which can vary in clinical aetiology 
and presentation, clarity on the criteria used to define, with 
explicit classification of acute and chronic HF along with 
ejection fraction would benefit understanding of results.
Comparing and Combining Data Sources
Only 14 (17%) studies validated primary care systems, 
more than half of which were in the UK. Using primary 
care EHRs may be beneficial for research into conditions 
such as HF which are frequently managed in primary care; 
in our study, 30% of HF EHR validation studies used 
primary care data, compared to 16% for ACS and 7% for 
stroke studies. For acute severe conditions resulting in 
hospitalization, secondary care records should be the 
most reliable data source. Where possible, the use of 
linked data to increase the ascertainment of acute CVD 
events should be considered.
Implications for Future Research
EHR-based research is a growing field – widely used in 
observational analyses and increasingly employed in 
trials.115 Researchers should consider the level of validity 
necessary for their own CVD outcome definition. When a 
composite outcome, such as MACE, is used researchers 
may need to address differing sensitivity in the individual 
components of the outcome. In studies which investigate 
CVD incidence, a sensitive definition is particularly 
important. For example, EHR data are being used for 
rapid COVID-19 pandemic analyses such as; the impact 
the virus has in those with CVD, CVD as an outcome after 
infection with the virus, and excess death estimates.116 It is 
important that these rapid analyses consider the validity of 
the data and definitions used. Conversely, in a pragmatic 
trial recruitment, a specific definition is likely more impor-
tant than a sensitive one.
Strengths and Limitations
Our systematic review provides a comprehensive and up-to- 
date evaluation of the validity of acute CVD diagnoses in 
European EHRs, conducted without language or time restric-
tions using a broad search strategy. Two independent reviewers 
performed our study selection, and native speaking collabora-
tors translated foreign language articles. Similar to other sys-
tematic reviews of validation studies, we repurposed the 
QUADAS-2 risk of bias tool developed for diagnostic test 
accuracy. Additionally, we followed the diagnostic test accu-
racy GRADE methodology to assess the overall evidence base.
Our work is not without limitations. Firstly, only one 
reviewer completed full data extraction and risk of bias 
assessment due to resource constraints, although a sample 
of 20% of studies had data dual extracted. Secondly, we 
limited our study to Europe, so theoretically our results are 
only generalizable to European countries. All previous 
systematic reviews8–12 on the validity of acute CVD diag-
noses included both EHRs and claim-based systems, while 
most studies included in each of these reviews were from 
North America. From these existing reviews, it was 
unclear if the validity of EHRs differed to claims-based 
datasets, which reflect payments related to medical care 
given. Despite this, we obtained similar results to the 
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previous reviews. Thirdly, our review focused on acute 
CVD events so excluded results from studies that validated 
broader diagnoses of ischaemic heart disease or cerebro-
vascular disease, which again limits generalizability to 
these specific conditions.
Recommendations
For ACS and stroke diagnoses, most sensitivity and PPV 
results were reasonably high, providing confidence in the 
use of European EHR data for research into these condi-
tions. However, there was considerable heterogeneity 
between studies. Sensitivity for HF diagnoses was low, 
and our GRADE assessment found very low quality for 
all HF outcomes. For studies of HF, we strongly recom-
mend either validating the definition or referring to exist-
ing validation studies to develop the case definition. New 
validation studies of HF diagnoses should report whether 
the diagnoses validated are for acute or chronic presenta-
tion and HF with reduced ejection fraction or preserved 
ejection fraction. These principles are also applicable to 
future ACS and stroke validation studies. Identifying spe-
cific stroke subtypes can be difficult; analysis of all stroke 
subtypes combined is preferable.
Conclusions
Our review on the accuracy of HF, ACS and stroke diag-
noses in European EHRs should guide researchers in their 
selection of data sources and CVD definitions for epide-
miological studies. Generally, the data assessed was of 
reasonable quality. However, it is difficult to summarize 
validity given the heterogeneity between studies. Where 
possible, researchers should validate data before use or 
carefully interpret the results of previous validation studies 
to consider the impact validity has on research findings. 
Additionally, the use of linked data will bolster quality.
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